Candriam S.C.A. Sells 106,420 Shares of Xylem Inc. $XYL

Candriam S.C.A. lowered its holdings in Xylem Inc. (NYSE:XYL) by 10.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 875,838 shares of the industrial products company’s stock after selling 106,420 shares during the quarter. Candriam S.C.A.’s holdings in Xylem were worth $89,020,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund raised its position in Xylem by 0.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 27,923 shares of the industrial products company’s stock worth $3,337,000 after purchasing an additional 100 shares in the last quarter. Thrive Wealth Management LLC boosted its holdings in Xylem by 2.1% during the second quarter. Thrive Wealth Management LLC now owns 5,032 shares of the industrial products company’s stock valued at $595,000 after purchasing an additional 104 shares in the last quarter. World Investment Advisors boosted its holdings in Xylem by 3.7% during the first quarter. World Investment Advisors now owns 3,319 shares of the industrial products company’s stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. Aventus Investment Advisors Inc. boosted its holdings in Xylem by 66.7% during the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 120 shares in the last quarter. Finally, Aprio Wealth Management LLC grew its stake in shares of Xylem by 6.2% in the 3rd quarter. Aprio Wealth Management LLC now owns 2,114 shares of the industrial products company’s stock valued at $214,000 after purchasing an additional 123 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 2.2%

Shares of XYL stock opened at $97.88 on Friday. The company has a market capitalization of $22.45 billion, a P/E ratio of 21.65, a P/E/G ratio of 1.63 and a beta of 1.01. Xylem Inc. has a 12-month low of $87.40 and a 12-month high of $152.15. The company has a quick ratio of 1.02, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average price of $103.56 and a 200 day moving average price of $116.48.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). The firm had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 12.06% and a net margin of 11.94%. Xylem’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.37 earnings per share. Research analysts forecast that Xylem Inc. will post 5.45 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Thursday, August 27th. Xylem’s payout ratio is presently 38.05%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on XYL. Wolfe Research initiated coverage on Xylem in a report on Tuesday, September 15th. They issued a “peer perform” rating for the company. Stifel Nicolaus cut their target price on Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a research report on Wednesday, October 28th. Argus lowered Xylem from a “buy” rating to a “hold” rating in a research note on Wednesday. The Goldman Sachs Group lowered their price target on Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research report on Wednesday, October 28th. Finally, Jefferies Financial Group increased their price objective on Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research note on Monday, August 24th. Nine investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Xylem has a consensus rating of “Hold” and an average price target of $121.31.

Insider Activity at Xylem

In other Xylem news, Director D Koch purchased 11,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 29th. The shares were acquired at an average cost of $89.60 per share, for a total transaction of $985,600.00. Following the transaction, the director directly owned 12,247 shares in the company, valued at approximately $1,097,331.20. The trade was a 882.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.32% of the stock is owned by insiders.

About Xylem

Xylem Inc is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure.

The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.

Xylem was established in 2011 when it became an independent company following its spin-off from ITT Corporation.